Summary
Samenvatting toegepaste dieetleer 2
Course
Toegepaste Dieetleer
Institution
Hogeschool Gent (HoGent)
Samenvatting van het vak toegepaste dieetleer 2, gegeven door mevrouw Lanssens in . Geslaagd in eerste zit dankzij deze samenvatting!
[Show more]
Preview 4 out of 95 pages
Uploaded on
January 22, 2022
Number of pages
95
Written in
2020/2021
Type
Summary
evidence based
dieetleer 2
Institution
Hogeschool Gent (HoGent)
Education
Bachelor Voedings- En Dieetkunde
Course
Toegepaste Dieetleer
All documents for this subject (3)
By: charlottethys • 2 year ago
$7.06
Also available in package deal from $15.21
Added
Add to cart
Add to wishlist
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
Samenvattingen dieetleer 1, 2, 3
1. Summary - Screeningtools ondervoeding
2. Summary - Antwoorden van alle vragen toegepaste dieetleer 3
3. Summary - Samenvatting toegepaste dieetleer 1
4. Summary - Samenvatting toegepaste dieetleer 2
Show more
Toegepaste
dieetleer 2
MORGAN LANSSENS
Lore De Moor
HOGENT | AJ 2020 - 2021
,1
,Inhoud
Hoofdstuk 1 hart- en vaatziekten ............................................................................................................. 8
Hypertensie .......................................................................................................................................... 8
Inleiding ............................................................................................................................................ 8
Indeling ............................................................................................................................................. 8
Streefwaarden .................................................................................................................................. 8
Diagnose .......................................................................................................................................... 8
Risicoprofiel ...................................................................................................................................... 9
Klachten............................................................................................................................................ 9
Minimale doelstelling ........................................................................................................................ 9
Behandeling ..................................................................................................................................... 9
Anti-atherogeen dieet ......................................................................................................................... 19
Begripsbepaling .............................................................................................................................. 19
Complicaties ................................................................................................................................... 19
Risicoprofiel .................................................................................................................................... 20
Lipoedeem ......................................................................................................................................... 30
Kenmerken ..................................................................................................................................... 30
Secundair lymfoedeem bij lipoedeem ............................................................................................ 30
Diagnose ........................................................................................................................................ 31
Behandeling ................................................................................................................................... 31
Metabool syndroom ........................................................................................................................... 32
Prevalentie ..................................................................................................................................... 32
Definitie........................................................................................................................................... 32
Criteria volwassenen ...................................................................................................................... 32
Criteria kinderen en adolescenten ................................................................................................. 32
Gevolgen ........................................................................................................................................ 33
Mechanisme ................................................................................................................................... 33
Hoofdstuk 2: overgewicht en obesitas ................................................................................................... 35
Nutritional assessment ....................................................................................................................... 35
Cliëntoriëntatie – hulpvraag/motivatie ............................................................................................ 35
Voedingsanamnese........................................................................................................................ 36
Antropometrie ................................................................................................................................. 39
Analyse medicatiegebruik .............................................................................................................. 42
Risicofactoren van (overgewicht)/obesitas ..................................................................................... 44
Co-morbiditeit en complicaties ....................................................................................................... 44
Diëtetische diagnose .......................................................................................................................... 45
Diëtetische diagnose miv risicoanalyse ......................................................................................... 45
Stadiëring volgens Edmonton Obesity Stage System (EOSS) ...................................................... 45
Eetstoornis: Binge Eating Disorder (BED) ..................................................................................... 46
Nutritional support .............................................................................................................................. 46
2
, Behandeldoel volgens BMI – Volwassenen ................................................................................... 46
Behandeldoel volgens RelRefG index – kinderen ......................................................................... 47
Behandeldoel – Voedingsinterventie .............................................................................................. 47
Behandeldoel – Gewichtsreductie .................................................................................................. 47
Advies – Minder eten...................................................................................................................... 47
Advies – Eiwitten ............................................................................................................................ 49
Advies – Vetten en koolhydraten ................................................................................................... 49
Advies – Meer bewegen ................................................................................................................. 49
Advies – Complexer dan Energie-inname < Energieverbruik of Energieverbruik > Energie-inname
........................................................................................................................................................ 49
Advies – Slaap ............................................................................................................................... 50
Aanpak externe eter ....................................................................................................................... 50
Aanpak emo-eter (ook lijngerichte) ................................................................................................ 51
Behandelplan kinderen................................................................................................................... 51
Hoofdstuk 3: Bariatrische heelkunde ..................................................................................................... 52
Normale gezonde voeding ................................................................................................................. 52
Wonderdiëten ..................................................................................................................................... 52
Meest gemaakte fouten bij vermagering ............................................................................................ 52
Spijsvertering ..................................................................................................................................... 52
Mondholte ....................................................................................................................................... 52
Slokdarm ........................................................................................................................................ 52
Maag............................................................................................................................................... 52
Twaalfvingerige darm ..................................................................................................................... 52
Nuchtere darm (jejunum)................................................................................................................ 52
De kronkeldarm (ileum) .................................................................................................................. 52
Dikke darm ..................................................................................................................................... 52
Endeldarm ...................................................................................................................................... 52
Anus ............................................................................................................................................... 52
Medicatie ............................................................................................................................................ 53
Maagverkleining ................................................................................................................................. 53
Voorwaarden .................................................................................................................................. 53
Soorten ........................................................................................................................................... 53
Gastric banding (maagband) .......................................................................................................... 54
Maagballon ..................................................................................................................................... 54
Gastric bypass ................................................................................................................................ 55
Mini gastric bypass ......................................................................................................................... 56
Gastric sleeve – maagverkleining .................................................................................................. 56
Scopinario ...................................................................................................................................... 57
Duodenal switch ............................................................................................................................. 57
Belangrijk ........................................................................................................................................... 57
3